Загрузка...
CAR therapy: the CD19 paradigm
Twenty-five years after its inception, the genetic engineering of T cells is now a therapeutic modality pursued at an increasing number of medical centers. This immunotherapeutic strategy is predicated on gene transfer technology to instruct T lymphocytes to recognize and reject tumor cells. Chimeri...
Сохранить в:
| Опубликовано в: : | J Clin Invest |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588281/ https://ncbi.nlm.nih.gov/pubmed/26325036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|